在晚期前列腺癌中确定雄激素受体变异合成的拼接因子要求
Laura Walker1, Ruaridh Duncan1, Beth Adamson1
1Newcastle University Centre for Cancer, Newcastle upon Tyne, United Kingdom.
Molecular cancer research : MCR
|September 30, 2024
概括
鉴定雄激素受体变体 (AR-V) 拼接的调节者对于克服前列腺癌治疗耐药性至关重要. 这项研究确定了MFAP1和CWC22作为AR-V生成的关键拼接因子,为割抵抗性前列腺癌提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 针对雄激素受体 (AR) 的疗法受到前列腺癌治疗耐药性的挑战.
- 抗割前列腺癌 (CRPC) 通常涉及构成性活跃的AR变体 (AR-Vs),驱动瘤进展.
- 对AR-V拼接调节的有限理解阻碍了新型治疗策略的开发.
研究的目的:
- 在前列腺癌中确定调节AR变体 (AR-Vs) 合成的新型拼接因子.
- 在CRPC中发现潜在的治疗点,以克服对AR向疗法的耐药性.
- 在CRPC模型中研究AR-V拼接调节器的功能影响.
主要方法:
- 一个定制的CRISPR屏幕被用来系统地描述AR-V合成的剪接因子要求.
- 在CRPC模型中进行了确定拼接因子 (MFAP1,CWC22) 的消耗.
- 全球转录基因分析是在MFAP1贫乏细胞上进行的.
主要成果:
- 确定MFAP1和CWC22对于AR-VmRNA转录生成至关重要.
- MFAP1和CWC22的耗尽降低了AR-V蛋白水平和CRPC细胞增殖.
- MFAP1下调使前列腺癌细胞对电离辐射敏感,影响DNA损伤反应通路.
结论:
- MFAP1和CWC22是前列腺癌中致病性AR拼接的关键调节者.
- 向AR-V拼接是CRPC的一个有前途的治疗策略.
- 在CRPC治疗中,MFAP1抑制可能会增强对DNA损伤剂 (如电离辐射) 的敏感性.
相关概念视频
RNA Splicing
56.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.1K
Alternative RNA Splicing
21.0K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K
Pre-mRNA Processing: RNA Splicing
5.2K
5.2K
Chromatin Structure Regulates pre-mRNA Processing
7.0K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
7.0K
Pre-mRNA Processing: Modification of pre-mRNA Ends
9.2K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
9.2K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K


